Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report

Abstract Background Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma. Case presentation We describe here the case of a 49 years-old woman with Aspirin-exacerbated respiratory disease (AERD), chronic rhinosinusit...

Full description

Bibliographic Details
Main Authors: C. Caruso, S. Colantuono, D. Pugliese, C. Di Mario, B. Tolusso, E. Gremese, G. Papparella, F. Castrì, A. Gasbarrini, A. Romano, A. Armuzzi
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
AERD
Eosinophilic
Asthma
Gastroenteritis
Online Access:http://link.springer.com/article/10.1186/s13223-020-00423-3

Internet

http://link.springer.com/article/10.1186/s13223-020-00423-3

Similar Items